| MERCK KGAA O.N. | 124.00 / +0.24% |
| Date/Time | 09/25 / 17:35 |
| Chg. / Chg.(%) | 0.30 / +0.24% |
| Bid | - |
| Ask | - |
| Open | 123.55 |
| Previous Close | 123.70 |
| High | 124.00 |
| Low | 121.90 |
| Volume [EUR] | 45,429,003.95 |
| Volume [Units] | 368,605 |
| Price fixings | 2488 |
| ISIN | DE0006599905 |
| Security | MRK |
| Exchange | Xetra |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 124.050 |  |
|
| Xetra | 124.00 | |
368,605 |
| London Inter.. | 123.35 | |
234,093 |
| Turquoise | 123.75 | |
50,361 |
| Cboe Europe .. | 123.55 | |
46,634 |
| Cboe Europe .. | 124.00 | |
35,273 |
| TradeGate | 124.600 | |
4,688 |
| Stuttgart | 124.200 | |
1,296 |
| gettex | 124.800 | |
594 |
| Frankfurt | 123.1000 | |
335 |
| München | 123.00 | |
194 |
| Borsa Italia.. | 123.50 | |
101 |
| Hannover | 122.85 | |
53 |
| Hamburg | 122.65 | |
49 |
| Nasdaq Other.. | 142.8000 |  |
10 |
| Düsseldorf | 122.90 | |
8 |
| Vienna Globa.. | 123.70 | |
0 |
| Berlin | 123.90 | |
0 |
| SIX Swiss Ex.. | 130.00 | |
|
| SIX Swiss Ex.. | 109.60 | |
|
| EUREX | Options | ||
News
- Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
09/17/2020 / 14:00 - GlobeNewswire - PTA-News: 4SC AG: 4SC expands avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer<BR/>for further clinical combination study of domatinostat in Merkel cell carcinoma
09/15/2020 / 07:30 - pressetext - NKMax America Announces a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer
09/09/2020 / 01:00 - GlobeNewswire - Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
08/06/2020 / 14:05 - GlobeNewswire - Merck EPS rise by 15% to $1.18 in Q2
07/31/2020 / 12:51 - TeleTrader
Real-time